Medical Meetings
Our success as a next-generation BioPharma company will be measured by the difference we can make in the lives of patients facing serious disease. Members of the press may learn more about our company, our philanthropy and our focus on innovative medicines by viewing these resources.
BMS at ASCO and EHA 2022
At this year’s ASCO and EHA meetings, we shared research across immuno-oncology, hematology and cell therapy that underscores our efforts in delivering long-term survival and improved outcomes for patients.